Insights on Discovery
-
Ethical, Considerations As Gene Editing Technologies Advance
6/26/2025
Observe as experts highlight innovative tools and strategies advancing the safety of gene editing therapies while addressing off-target effects, regulatory demands, and manufacturing efficiency.
-
How The Pharma Industry Is Closing Health Inequities
6/26/2025
Witness as pharma leaders discuss advancing equity through inclusive trial design, access planning, and global partnerships to overcome persistent health disparities and expand access to lifesaving therapies worldwide.
-
Guide To Seeding, Expanding, And Harvesting Stem Cells
6/18/2025
Investigate important considerations for working with three different stem cell types: mesenchymal stem/stromal cells, induced pluripotent stem cells, and neural stem cells.
-
What ASCO 2025 Means For The Future Of Oncology Trials
6/13/2025
Review the ASCO 2025 Annual Meeting, highlighting oncology trials and the need for agile, globally capable CRO partners to navigate today’s evolving trial landscape.
-
Factors Influencing CD34+ Cell Collection Efficiency In Leukapheresis
6/3/2025
Efficiently collecting sufficient peripheral blood stem cells is paramount for successful transplantation, necessitating a deeper understanding of influencing factors and procedural nuances.
-
Broad Biodistribution And Expression Of Allele-Selective LETI-101
5/28/2025
Discover how LETI-101, a novel precision-based CRISPR treatment, can leverage targeted delivery and broad brain distribution to transform Huntington's disease treatment.
-
CRISPR Portfolio, Modalities Accelerate Candidate Identification
5/28/2025
See how this cutting-edge, AI-driven genome editing technology can accelerate the development of precise, clinically viable therapies for genetic diseases.
-
Peripheral Blood Mononuclear Cell (PBMC) Isolation Using Cell Fractionation Filters
5/28/2025
Discover how this Peripheral Blood Mononuclear Cell (PBMC) isolation method can transform CAR-T manufacturing by reducing costs, accelerating timelines, and improving patient accessibility.
-
Signature Of Base Editor RNA Edits And Reduced Exogenous RNA Editing
5/28/2025
Learn how this groundbreaking method for distinguishing base editor-induced RNA edits can enhance the safety and efficacy of genomic medicines.
-
Electroporation, LNPs For Targeted CRISPR/Cas9 Gene Editing In T-Cells
5/28/2025
This study compared non-viral transfection methods in primary human T-cells, demonstrating the feasibility of an LNP-based process encapsulating CRISPR/Cas9 and HDR template DNA in a single payload.